olivlawolivlaw

olivLaw · US equity research

Donaldson Company, Inc. DCI

Industrial & Commercial Fans & Blowers & Air Purifing Equip · SIC 3564 · Vertical: Industrial machinery and computer equipment (SIC 356x)

85.52USD−0.44% · 1 dayClose 04 Nov 2026

Donaldson is a global leader in technology-led filtration products and solutions, with more than 150 locations on six continents. The company closed fiscal 2026 with net sales of 3885.6 million USD, up 5.3%, and its fiscal 2027 guidance projects another record year as it integrates the Facet acquisition.

At the close of 04 Nov 2026, Donaldson Company, Inc. (DCI) stock was 85.52 USD (−0.44% on the day), with market capitalisation 9.9 bn USD, P/E 22.2 on diluted EPS of 3.85 USD over the last 12 months, dividend yield 1.45%, beta 0.87, 52-week range 81.55–110.57 USD. Latest reported quarter (Q4 2026): revenue of 1.1 bn USD (+8.0% YoY), net income of 129.3 m USD (+13.1% YoY), diluted EPS 1.10 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
9.9 bn USD
shares as of 11 Sept 2026
P/E (TTM)
22.2
Diluted EPS TTM 3.85 · TTM to 31 Jul 2026
E/P (TTM)
4.50%
TTM to 31 Jul 2026
Dividend yield
1.45%
DPS 12m 1.24
Beta (2y)
0.87
Volatility (1y) 27%
52-week range
81.55110.57

Price history

Loading chart…

Technical reading

RSI (14)
45.3
neutral
Bollinger (20, 2)
83.66 – 88.96
in the lower half of the band · %B 0.35 · band width 6.1%
SMA 50 / 200
87.75 / 90.42
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
-0.84 / -0.83
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−4.1%−1.1%−3.0 pp—
3 months−12.1%−0.5%−11.6 pp—
6 months−2.4%+4.4%−6.8 pp—
Year to date−3.5%+12.3%−15.9 pp—
1 year+1.1%+13.5%−12.4 pp+8.3%
3 years+43.5%+76.4%−32.9 pp+42.6%
5 years+39.2%+63.7%−24.4 pp—
Max drawdown (1y)
−26.2%
11 Feb 2026 → 19 May 2026
Max drawdown (5y)
−26.2%
11 Feb 2026 → 19 May 2026
Compound annual growth (5y)
+6.8%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q4 2026 · 31 Jul 2026

Revenue
1.1 bn USD
+8.0% YoY
Net income
129.3 m USD
+13.1% YoY
Diluted EPS
1.10
+13.2% YoY
net / operating
12.2% / 16.7%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Revenue900.1 m870.0 m940.1 m980.7 m935.4 m896.3 m995.1 m1.1 bn
Cost of revenue580.5 m564.1 m618.2 m641.9 m606.6 m596.5 m661.7 m674.9 m
Gross profit319.6 m305.9 m321.9 m338.8 m328.8 m299.8 m333.4 m383.9 m
Research & development22.7 m21.2 m21.4 m22.5 m19.2 m18.6 m19.2 m19.1 m
SG&A166.1 m159.2 m152.3 m164.6 m169.6 m162.5 m158.9 m188.2 m
Operating income130.8 m125.5 m87.4 m151.7 m149.3 m118.7 m155.3 m176.6 m
Depreciation & amortisation25.5 m25.0 m ≈24.6 m ≈24.4 m24.3 m24.6 m ≈24.1 m ≈33.0 m
Interest expense5.5 m5.9 m5.7 m7.1 m7.1 m7.7 m6.5 m14.7 m
Pre-tax income130.5 m125.0 m87.0 m149.7 m147.5 m116.6 m154.8 m166.9 m
Income tax31.5 m29.1 m29.2 m35.4 m33.6 m24.1 m36.7 m37.6 m
Net income99.0 m95.9 m57.8 m114.3 m113.9 m92.5 m118.1 m129.3 m
Diluted EPS0.810.790.480.97 ≈0.970.781.001.10 ≈
Operating cash flow72.9 m90.4 m ≈87.7 m ≈167.8 m125.4 m33.0 m ≈135.4 m ≈199.9 m
Capex25.1 m18.9 m ≈16.3 m ≈18.6 m14.2 m15.0 m ≈23.3 m ≈14.9 m
Dividends paid32.4 m32.2 m ≈32.3 m ≈35.0 m34.7 m34.6 m ≈34.7 m ≈37.2 m
Share repurchases74.4 m7.2 m ≈190.6 m ≈59.3 m91.5 m19.7 m ≈0 ≈0

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 35 percentile of its own 40-quarter history (min 19.5, median 23.9, max 49.7; quarters with earnings only).

Fiscal years

Fiscal year20192020202120222023202420252026
Revenue2.8 bn2.6 bn2.9 bn3.3 bn3.4 bn3.6 bn3.7 bn3.9 bn
Revenue YoY+4.0%−9.2%+10.5%+15.9%+3.8%+4.5%+2.9%+5.3%
Net income267.2 m257.0 m286.9 m332.8 m358.8 m414.0 m367.0 m453.8 m
Net income YoY+48.2%−3.8%+11.6%+16.0%+7.8%+15.4%−11.4%+23.7%
Diluted EPS2.052.002.242.662.903.383.053.85
Diluted EPS YoY+50.7%−2.4%+12.0%+18.8%+9.0%+16.6%−9.8%+26.2%
net %9.4%10.0%10.1%10.1%10.5%11.5%9.9%11.7%
Free cash flow195.1 m262.6 m342.9 m167.3 m426.0 m406.9 m339.9 m426.3 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 31 Jul 2026

Cash
250.4 m USD
Financial debt
1.3 bn USD
Net debt
1.1 bn USD
Equity
1.8 bn USD
Total assets
4.0 bn USD
Debt / equity
0.75x
Current ratio
2.08x
ROE
28.2%
ROA
13.0%
FCF margin
11.0%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
3.6 bn
2025
3.7 bn
2026
3.9 bn

SEC (XBRL)· 25 Sept 2026verified

Cost of revenue
2024
2.3 bn
2025
2.4 bn
2026
2.5 bn

SEC (XBRL)· 25 Sept 2026verified

Gross profit
2024
1.3 bn
2025
1.3 bn
2026
1.3 bn

SEC (XBRL)· 25 Sept 2026verified

Research & development
2024
93.6 m
2025
87.8 m
2026
76.1 m

SEC (XBRL)· 25 Sept 2026verified

SG&A
2024
636.7 m
2025
642.2 m
2026
679.2 m

SEC (XBRL)· 25 Sept 2026verified

Operating income
2024
544.1 m
2025
495.4 m
2026
599.9 m

SEC (XBRL)· 25 Sept 2026verified

Depreciation & amortisation
2024
98.4 m
2025
99.5 m
2026
106.0 m

SEC (XBRL)· 25 Sept 2026verified

EBITDA
2024
642.5 m ≈
2025
594.9 m ≈
2026
705.9 m ≈

SEC (XBRL)· 25 Sept 2026derived

Interest expense
2024
21.4 m
2025
24.2 m
2026
36.0 m

SEC (XBRL)· 25 Sept 2026verified

Pre-tax income
2024
535.3 m
2025
492.2 m
2026
585.8 m

SEC (XBRL)· 25 Sept 2026verified

Income tax
2024
121.3 m
2025
125.2 m
2026
132.0 m

SEC (XBRL)· 25 Sept 2026verified

Net income
2024
414.0 m
2025
367.0 m
2026
453.8 m

SEC (XBRL)· 25 Sept 2026verified

Diluted EPS
2024
3.38
2025
3.05
2026
3.85

SEC (XBRL)· 25 Sept 2026verified

Weighted average diluted shares
2024
122.6 m
2025
120.4 m
2026
117.9 m

SEC (XBRL)· 25 Sept 2026verified

Dividend per share
2024
1.04
2025
1.14
2026
1.24

SEC (XBRL)· 25 Sept 2026verified

Balance sheet · USD

Cash
2024
232.7 m
2025
180.4 m
2026
250.4 m

SEC (XBRL)· 25 Sept 2026verified

Receivables
2024
629.7 m
2025
662.2 m
2026
758.1 m

SEC (XBRL)· 25 Sept 2026verified

Inventories
2024
476.7 m
2025
513.6 m
2026
538.7 m

SEC (XBRL)· 25 Sept 2026verified

Current assets
2024
1.4 bn
2025
1.5 bn
2026
1.7 bn

SEC (XBRL)· 25 Sept 2026verified

Property, plant & equipment, net
2024
645.5 m
2025
644.5 m
2026
633.3 m

SEC (XBRL)· 25 Sept 2026verified

Goodwill
2024
478.4 m
2025
493.6 m
2026
1.1 bn

SEC (XBRL)· 25 Sept 2026verified

Intangibles (excl. goodwill)
2024
171.9 m
2025
97.4 m
2026
304.6 m

SEC (XBRL)· 25 Sept 2026verified

Total assets
2024
2.9 bn
2025
3.0 bn
2026
4.0 bn

SEC (XBRL)· 25 Sept 2026verified

Accounts payable
2024
379.4 m
2025
368.6 m
2026
378.6 m

SEC (XBRL)· 25 Sept 2026verified

Short-term debt
2024
28.3 m
2025
31.2 m
2026
44.8 m

SEC (XBRL)· 25 Sept 2026verified

Long-term debt
2024
510.0 m
2025
640.0 m
2026
1.3 bn

SEC (XBRL)· 25 Sept 2026verified

Current liabilities
2024
782.5 m
2025
757.2 m
2026
804.1 m

SEC (XBRL)· 25 Sept 2026verified

Total liabilities
2024
1.4 bn
2025
1.5 bn
2026
2.2 bn

SEC (XBRL)· 25 Sept 2026verified

Equity
2024
1.5 bn †
2025
1.5 bn †
2026
1.8 bn †

SEC (XBRL)· 25 Sept 2026verified

Cash flow · USD

Operating cash flow
2024
492.5 m
2025
418.8 m
2026
493.7 m

SEC (XBRL)· 25 Sept 2026verified

Capex
2024
85.6 m
2025
78.9 m
2026
67.4 m

SEC (XBRL)· 25 Sept 2026verified

Free cash flow
2024
406.9 m ≈
2025
339.9 m ≈
2026
426.3 m ≈

SEC (XBRL)· 25 Sept 2026derived

Investing cash flow
2024
-86.9 m
2025
-150.4 m
2026
-879.5 m

SEC (XBRL)· 25 Sept 2026verified

Financing cash flow
2024
-355.9 m
2025
-321.7 m
2026
451.6 m

SEC (XBRL)· 25 Sept 2026verified

Dividends paid
2024
122.8 m
2025
131.9 m
2026
141.2 m

SEC (XBRL)· 25 Sept 2026verified

Share repurchases
2024
162.7 m
2025
331.5 m
2026
111.2 m

SEC (XBRL)· 25 Sept 2026verified

Computed indicators

Growth

Revenue growth (YoY)
5.3%
computed by olivLawFY 2026
Revenue CAGR 3Y
4.2%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
6.4%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
21.1%
computed by olivLawFY 2026
Net income growth (YoY)
23.7%
computed by olivLawFY 2026
Net income CAGR 3Y
8.1%
computed by olivLawFY 2023 → FY 2026
Net income CAGR 5Y
9.6%
computed by olivLawFY 2021 → FY 2026
EPS growth (YoY)
26.2%
computed by olivLawFY 2026
EPS CAGR 3Y
9.9%
computed by olivLawFY 2023 → FY 2026
EPS CAGR 5Y
11.4%
computed by olivLawFY 2021 → FY 2026
FCF growth (YoY)
25.4%
computed by olivLawFY 2026

Profitability

Gross margin
34.6%
computed by olivLawFY 2026
EBITDA margin
18.2%
computed by olivLawFY 2026
EBIT margin
15.4%
computed by olivLawFY 2026
Net margin
11.7%
computed by olivLawFY 2026
FCF margin
11.0%
computed by olivLawFY 2026

Returns

ROE
28.2%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
ROA
13.0%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
ROIC
19.4%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
ROCE
18.8%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Payout ratio (EPS)
32.2%
computed by olivLawFY 2026
Payout ratio (FCF)
33.1%
computed by olivLawFY 2026

Balance sheet

Net debt
1.1 bn USD
computed by olivLawbalance sheet at 31 Jul 2026
Net debt / EBITDA
1.5x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Debt / equity
0.8x
computed by olivLawbalance sheet at 31 Jul 2026
Interest coverage
16.7x
computed by olivLawFY 2026

Liquidity

Current ratio
2.1x
computed by olivLawbalance sheet at 31 Jul 2026
Quick ratio
1.4x
computed by olivLawbalance sheet at 31 Jul 2026
Cash ratio
0.3x
computed by olivLawbalance sheet at 31 Jul 2026

Cash

Operating cash flow
493.7 m USD
computed by olivLawFY 2026
Capital expenditure
67.4 m USD
computed by olivLawFY 2026
Free cash flow
426.3 m USD
computed by olivLawFY 2026
FCF conversion
93.9%
computed by olivLawFY 2026
Cash conversion
69.9%
computed by olivLawFY 2026

Efficiency

Days sales outstanding
67 days
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Days inventory outstanding
76 days
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Days payables outstanding
54 days
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Cash conversion cycle
89 days
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026

Market and valuation

Market capitalisation
9.9 bn USD
computed by olivLawbalance sheet at 31 Jul 2026
Enterprise value
11.0 bn USD
computed by olivLawbalance sheet at 31 Jul 2026
Market cap / net income TTM
21.8x
computed by olivLawFY 2026
P/E (TTM)
22.2x
computed by olivLawFY 2026
Earnings yield
4.5%
computed by olivLawFY 2026
P/B
5.6x
computed by olivLawbalance sheet at 31 Jul 2026
P/S
2.6x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
EV/EBITDA
15.6x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
EV/EBIT
18.3x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
EV/Sales
2.8x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
P/FCF
23.3x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
FCF yield
4.3%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Dividend yield
1.4%
computed by olivLawFY 2026
Shareholder yield (distributions)
2.5%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026

Risk

Altman Z
5.43
computed by olivLawbalance sheet at 31 Jul 2026

Valuation

olivLaw classification

Neutral profile

Score: 69 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

85.52 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 9.9 bn USD

Key indicators

Market capitalisation
9.9 bn USD
computed by olivLawbalance sheet at 31 Jul 2026
P/E (TTM)
22.2x
computed by olivLawFY 2026
P/B
5.6x
computed by olivLawbalance sheet at 31 Jul 2026
EV/EBITDA
15.6x
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
ROE
28.2%
computed by olivLawFY 2026 · balance sheet at 31 Jul 2026
Net margin
11.7%
computed by olivLawFY 2026
Revenue growth (YoY)
5.3%
computed by olivLawFY 2026
Dividend yield
1.4%
computed by olivLawFY 2026

Coverage and freshness

36/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 31 Jul 2026
Latest balance sheet date: 31 Jul 2026
Share count (cover of the latest filing), as of: 11 Sept 2026
Source: SEC (XBRL)published 25 Sept 2026
verified 2867derived 226

Score by group

  • Valuation67
  • Balance sheet72
  • Quality84
  • Growth51
  • Returns62

Estimated value range

Low
58.16
USD per share
Mid
71.29
USD per share
High
100.95
USD per share
Price: 85.52 USD
The price is within the range
Potential to the central value: -16.6% (value / price − 1)
Margin of safety: -20.0% (1 − price / value)
Agreement between methods: medium · 4 methods used · 3 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 16.29 – 128.77 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)45.49 – 77.21 (Mid 57.57)
    WACC 8.8% · starting FCFF 454.2 m USD · terminal value share of EV 75%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 20.4%
  • Peers: EV/EBITDA70.84 – 124.68 (Mid 85.01)
    14 companies used · median multiple 15.5x · quartiles 13.2x – 22.0x
    ESAB, FLS, GGG, GHM, GRC, GTES, IR, ITT, NDSN, PPIH, RBC, TKR, XYL, ZBRA
  • Peers: P/E91.22 – 128.77 (Mid 103.35)
    21 companies used · median multiple 26.8x · quartiles 23.7x – 33.4x
    EFXT, ESAB, FLS, GGG, GRC, GTES, HSAI, IEX, IR, ITT, ITW, NDSN, PPIH, RBC, RRX, TAYD, TKR, TWIN, XYL, ZBRA, ZWS
  • Dividend discount (DDM)16.29 – 21.91 (Mid 18.69)
Multiple comparisons use the SIC vertical: Industrial machinery and computer equipment (SIC 356x)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 69/100

FactorValueScoreWeight used
ROIC · Quality19.4%90 (vs peers)10%
Net margin · Quality11.7%69 (vs peers)6%
FCF conversion · Quality93.9%91 (on a fixed band)6%
Revenue CAGR 3Y · Growth4.2%35 (on a fixed band)8%
EPS CAGR 3Y · Growth9.9%66 (on a fixed band)8%
Net debt / EBITDA · Balance sheet1.5x44 (vs peers)10%
Interest coverage · Balance sheet16.7x100 (on a fixed band)6%
Current ratio · Balance sheet2.1x100 (on a fixed band)4%
P/E (TTM) · Valuation22.2x84 (vs peers)10%
EV/EBITDA · Valuation15.6x61 (vs peers)10%
FCF yield · Valuation4.3%54 (on a fixed band)8%
Shareholder yield (distributions) · Returns2.5%36 (on a fixed band)6%
Payout ratio (FCF) · Returns33.1%100 (on a fixed band)4%

Score groups

  • Balance sheet72/100 · 3/3 factors with a value
  • Growth51/100 · 2/2 factors with a value
  • Quality84/100 · 3/3 factors with a value
  • Returns62/100 · 2/2 factors with a value
  • Valuation67/100 · 3/3 factors with a value

Memo

Donaldson Company, Inc. (DCI). Latest full fiscal year: 2026; data up to 2026-07-31.

Figures computed from the financial statements: revenue 3.9 bn USD in 2026; YoY growth 5.3%; net margin 11.7%; ROE 28.2%; net debt/EBITDA 1.5x.

The estimated value range is 58.16–100.95 USD per share (median of 4 methods, agreement: medium); assumptions are illustrative. Against the central value of 71.29 USD, the price of 85.52 USD leaves a potential of -16.6% (value / price − 1) and a margin of safety of -20.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 69/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 19.4%
  • FCF conversion: 93.9%
  • Interest coverage: 16.7x
  • Current ratio: 2.1x
  • P/E (TTM): 22.2x
  • Payout ratio (FCF): 33.1%

What contradicts it

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

Versus the vertical median

Industrial machinery and computer equipment (SIC 356x) · same industry group (3-digit SIC) · compared with 36 companies

Multiples and returns vs the median

P/E
22.2x
vertical median 27.9x
below median (−20.2%)
EV/EBITDA
15.6x
vertical median 18.0x
below median (−13.4%)
P/S
2.6x
vertical median 3.3x
below median (−23.6%)
P/B
5.6x
vertical median 3.1x
above median (+82.5%)
ROE
28.2%
vertical median 8.9%
above median (+215.2%)
Net margin
11.7%
vertical median 6.9%
above median (+69.5%)
EBIT margin
15.4%
vertical median 11.2%
above median (+37.6%)
Revenue YoY
5.3%
vertical median 8.3%
below median (−36.1%)
Net debt/EBITDA
1.5x
vertical median 1.3x
above median (+20.7%)
Dividend yield
1.4%
vertical median 0.9%
above median (+56.3%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ITWIllinois Tool Works Inc83.4 bn26.1101.7%19.4%+0.9%+18% / +21%
IRIngersoll Rand Inc.32.3 bn23.713.4%17.2%+5.7%+5% / +18%
XYLXylem Inc.23.2 bn22.310.1%11.9%+5.5%−28% / −4%
SYMSymbotic Inc.22.7 bn780.51.8%0.3%+25.7%−55% / −29%
NDSNNordson Corporation18.4 bn33.417.8%18.6%+3.8%+39% / +41%
ITTItt Inc.18.0 bn39.411.5%8.9%+8.5%+9% / +86%
IEXIdex Corp17.2 bn32.413.3%14.6%+5.8%+34% / +16%
ZBRAZebra Technologies Corporation15.7 bn26.816.5%9.8%+8.3%+32% / +40%
RBCRbc Bearings Incorporated15.1 bn42.710.5%17.5%+14.3%+7% / +85%
RRXRegal Rexnord Corp11.5 bn50.13.4%3.8%−1.6%+19% / +45%
GGGGraco Inc.11.2 bn22.520.4%22.4%+5.8%−15% / −14%
FLSFlowserve Corp10.3 bn40.711.1%—unavailable+14% / +112%
DCIDonaldson Company, Inc.9.9 bn22.228.2%11.7%+5.3%+1% / +43%
ZWSZurn Elkay Water Solutions Corporation7.5 bn26.317.7%15.9%+8.3%−5% / +53%
TKRTimken Co7.3 bn26.48.9%5.9%+0.2%+31% / +47%
GTESGates Industrial Corporation Ltd.6.1 bn17.010.6%10.4%+1.0%+7% / +100%
ESABESAB Corporation4.9 bn31.76.7%5.1%+3.7%−30% / +2%
CECOCeco Environmental Corp.2.7 bn—-2.6%-3.4%+38.8%−13% / +136%
EFXTEnerflex Ltd2.5 bn39.36.0%2.5%+6.5%+46% / +377%
OUSTOuster, Inc.2.4 bn—-11.3%-20.4%+52.5%+46% / +555%
HSAIHesai Group2.0 bn30.46.9%14.4%+52.1%−32% / +23%
GRCThe Gorman-Rupp Company2.0 bn26.317.0%10.2%+3.4%+59% / +134%
CHRNChronoscale Holdings Corporation1.8 bn—-42.0%-70.3%+459.4%+155% / −54%
GHMGraham Corporation816.0 m67.17.5%4.5%+16.9%+21% / +275%
TWINTwin Disc, Incorporated370.7 m11.916.3%8.0%+11.9%+64% / +86%

1- and 3-year price returns: for DCI from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
51.27
Total return -39% · Per year -39%
90.65
Total return 8% · Per year 8%
136.56
Total return 62% · Per year 62%
3 years
49.49
Total return -39% · Per year -15%
98.49
Total return 20% · Per year 6%
162.95
Total return 97% · Per year 25%
5 years
47.78
Total return -39% · Per year -9%
107.02
Total return 34% · Per year 6%
194.45
Total return 139% · Per year 19%
What moves the 3-year price the most
  • Exit P/E± 24.62
  • Net margin± 17.24
  • Annual revenue growth± 14.18
  • Annual dilution± 1.45

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Donaldson is a global leader in technology-led filtration products and solutions, with more than 150 locations on six continents. The company closed fiscal 2026 with net sales of 3885.6 million USD, up 5.3%, and its fiscal 2027 guidance projects another record year as it integrates the Facet acquisition.

SWOT

Strengths

  • The company holds a recognized leading position in several product lines and has a broad geographic footprint with plants and distribution centers on six continents 1.
  • Diversification across regions, end markets and customer types has limited the impact of weakness in any single area on consolidated results 1.
  • Higher operating margin and profitability in the fourth quarter show the teams' ability to execute 2.

Weaknesses

  • The Facet acquisition increased debt and interest costs, which weighs on near-term profitability 1.
  • Production inefficiencies in power generation equipment weighed on gross margin in fiscal 2026 1.
  • Dependence on raw materials such as steel and filter media exposes the company to cost volatility 1.

Opportunities

  • Integrating Facet in aerospace and defense could support sales growth in higher-margin segments 2.
  • Demand in bioprocessing and data centers could expand the Life Sciences segment if current trends continue 1.
  • Market share gains in the replacement parts market could increase recurring revenue 2.

Threats

  • Tariffs and retaliatory trade measures could raise costs and reduce the competitiveness of products in export markets 1.
  • If geopolitical tensions worsen, customer activity and the company's costs could be significantly affected 1.
  • Alternative technologies to diesel engines could reduce demand for some products 1.

Risks

  • Global operating riskshigh

    International operations expose the company to different regulations, tariffs, political risks and difficulties in protecting intellectual property 1.

  • Tariff pressurehigh

    New tariffs or increases could disrupt supply chains and reduce product competitiveness 1.

  • Supply chainmedium

    Supplier delays and raw material cost volatility could affect deliveries and margins 1.

  • Acquisition integrationmedium

    Integrating Facet and other acquisitions could generate unexpected costs and divert management attention 1.

  • Concentration in cyclical industrieslow

    Many customers operate in cyclical industries such as construction, agriculture and mining, which makes sales sensitive to the economic cycle 1.

Investment thesis

What would need to be true (bull case)

  • If the fiscal 2027 guidance is delivered, the company could report another record in sales and earnings, supported by organic growth and the Facet integration 2.
  • Improving performance in Industrial Solutions and a higher operating margin could support profitability over the medium term 2.
  • A leading position in niche markets and replacement parts could generate stable recurring revenue 1.

What would break the thesis

  • Higher debt after the Facet acquisition could limit financial flexibility if results fall short of guidance 2.
  • Tariffs and geopolitical tensions could reduce margins and demand in several regions 1.
  • If alternatives to diesel expand quickly, demand for some products could decline 1.

What to watch

  • Delivery of the fiscal 2027 sales and EPS guidance2027
  • Operating margin against the guided range of 16.6% to 17.2%2027
  • Effect of tariffs and tariff refunds on costsnext 10-K
  • Facet contribution and integration in aerospace and defenseQ1 2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Founded in 1915, Donaldson Company, Inc. develops filtration products for customers ranging from small business owners to the largest original equipment manufacturers. The company operates in four regions; the U.S. and Canada accounted for 42.5% of fiscal 2026 revenue and EMEA for 29.2% 1. Its strategy rests on extending market access, expanding technologies and solutions, and pursuing strategic acquisitions in high-margin areas 1.

The reportable segments are Mobile Solutions, Industrial Solutions and Life Sciences. Mobile Solutions is the largest, while Life Sciences covers food and beverage filtration, disk drive, membranes, microelectronics and bioprocessing. The Facet Filtration acquisition strengthened the company's position in aerospace and defense and in power generation 1.

In the fourth quarter of fiscal 2026 Donaldson reported record sales, and its fiscal 2027 outlook points to continued growth, with Facet-related costs and interest expense weighing on the cost base 2.

Segments

Mobile Solutions

The segment represents 62.3% of fiscal 2026 net sales and serves construction, mining, agriculture and transportation end markets, as well as the replacement parts market. It includes the Off-Road, On-Road and Aftermarket business units 1.

Industrial Solutions

The segment represents 29.1% of fiscal 2026 net sales and covers dust collection, industrial gases, hydraulics, power generation and aerospace and defense. The Facet acquisition added significant aerospace and defense sales to this segment 12.

Life Sciences

The segment represents 8.6% of fiscal 2026 net sales and includes food and beverage filtration, disk drive, advanced membranes, microelectronics and upstream and downstream bioprocessing 1.

Market context

Donaldson operates in highly competitive filtration markets where it considers itself a leader in several product lines, particularly for OEM off-road and on-road products and replacement filters. End markets are partly cyclical, and diversification across regions and customers has limited the impact of weakness in any single market 1.

Demand in Life Sciences has grown with data storage needs and cell and gene therapy development, and the fiscal 2027 outlook anticipates growth of 7% to 11% in this segment 12.

Trends

  • Trade tariffsmixed

    Tariffs imposed by the U.S. and retaliatory measures could raise costs and disrupt supply chains. The February 2026 Supreme Court decision and the expected recoveries leave the eventual effect still uncertain 1.

  • Electrification of equipmentheadwind

    A shift to alternatives to diesel engines could reduce demand for some products, though it could also open new markets for filtration technologies 1.

  • Demand for data centers and advanced therapiestailwind

    Growing data storage capacity and cell and gene therapies support demand in the Life Sciences segment 1.

  • Geopolitical tensions in the Middle Eastheadwind

    The conflict involving Iran has caused significant volatility in energy and commodity prices, which could affect costs and customer activity if tensions persist 1.

Competitive position

The main methods of competition are technology, innovation, product performance, service, price and geographic coverage. Mobile Solutions faces several large global competitors and many regional competitors, especially in the aftermarket 1.

In Industrial Solutions competitors vary from country to country, from large global groups to many smaller firms, while Life Sciences faces both large global competitors and niche players 1.

  • Large global competitors in Mobile Solutions

    The source mentions several large global competitors without naming them.

  • Regional competitors in the replacement parts market

    Numerous regional competitors are active, especially in the aftermarket, according to the source.

  • Local competitors in Industrial Solutions

    Competitors vary by country and include smaller firms focused on regions or limited applications.

  • Niche players in Life Sciences

    The source mentions niche players in individual end markets of the segment, without names.

News & filings

In the press

The latest news item in our archive is from 21 Oct 2026; the newest SEC filing is from 29 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2026-07-31 · SEC / Donaldson Company, Inc. · 25 Sept 2026
  2. [2] Form 8-K, results release (exhibit 99.1) · SEC / Donaldson Company, Inc. · 26 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.